However, in line with what was seen for chemerin, in the normal-weight group, CMKLR1 expression was predominant in women with PCOS, even if the difference with the ECHO group failed to reach statistical significance (Figure 2E). The gene discussed is RARRES2; the disease is polycystic ovary syndrome.